Cancer-associated fibroblast derived CXCL14 drives cisplatin chemoresistance by enhancing nucleotide excision repair in bladder cancer. Li T, Zhu K, Tong H, Sun Y, et al. J Exp Clin Cancer Res 2025;44:265.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li T, Zhu K, Tong H, Sun Y, et al. Cancer-associated fibroblast derived CXCL14 drives cisplatin chemoresistance by enhancing nucleotide excision repair in bladder cancer. J Exp Clin Cancer Res 2025;44:265.
PMID: 40898244